TG Therapeutics, Inc. (TGTX) on Decifer

Decifer ranks TGTX number 268 of 269 tracked names on durable business quality.

Why it ranks here

• Sales are growing about 87% a year, faster than 95 in 100 companies we measure.
• On making cash and being able to carry its debts it is safer than 52 in 100 companies we measure.
• It earns about 56% a year on the money put into the business, better than 98 in 100 companies we measure.
• It costs about 96 times its yearly profit; the middle of its industry is 25. Cheaper than 6 in 100 companies we measure, against their own industries.

The current read

The evidence on TGTX lines up on the supportive side: the conviction engine rates the evidence on this name strongly supportive. The independent signals we track are telling the same story.

Read the full TGTX research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.